Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.

Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.

Vitale A, Huo TL, Cucchetti A, Lee YH, Volk M, Frigo AC, Cescon M, Tuci F, Pinna AD, Cillo U.

Ann Surg Oncol. 2015;22(6):1901-7. doi: 10.1245/s10434-014-4099-2. Epub 2014 Sep 19.

PMID:
25234023
2.

Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.

Vitale A, Cucchetti A, Qiao GL, Cescon M, Li J, Ramirez Morales R, Frigo AC, Xia Y, Tuci F, Shen F, Cillo U, Pinna AD.

J Hepatol. 2014 Jun;60(6):1165-71. doi: 10.1016/j.jhep.2014.01.022. Epub 2014 Feb 6.

PMID:
24508550
3.

A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.

Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U; Liver Transplantation North Italy Transplant program (NITp) working group.

J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Epub 2013 Oct 23. Erratum in: J Hepatol. 2014 Jun;60(6):1336. Multiple investigator names added.

PMID:
24161408
4.

Histological differentiation predicts post-liver transplantation survival time.

Li WX, Li Z, Gao PJ, Gao J, Zhu JY.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):201-8. doi: 10.1016/j.clinre.2013.11.002. Epub 2013 Dec 30.

PMID:
24388339
5.

Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.

Sapisochin G, Castells L, Dopazo C, Bilbao I, Minguez B, Lázaro JL, Allende H, Balsells J, Caralt M, Charco R.

Ann Surg Oncol. 2013 Apr;20(4):1194-202. doi: 10.1245/s10434-012-2655-1. Epub 2012 Sep 11.

PMID:
22965574
6.

Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.

Berry K, Ioannou GN.

Gastroenterology. 2015 Sep;149(3):669-80; quiz e15-6. doi: 10.1053/j.gastro.2015.05.025. Epub 2015 May 27.

PMID:
26021233
7.

Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma.

Barreto SG, Brooke-Smith M, Dolan P, Wilson TG, Padbury RT, Chen JW.

ANZ J Surg. 2013 May;83(5):331-5. doi: 10.1111/j.1445-2197.2012.06196.x. Epub 2012 Sep 3.

PMID:
22943449
8.

The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.

Sumie S, Nakashima O, Okuda K, Kuromatsu R, Kawaguchi A, Nakano M, Satani M, Yamada S, Okamura S, Hori M, Kakuma T, Torimura T, Sata M.

Ann Surg Oncol. 2014 Mar;21(3):1002-9. doi: 10.1245/s10434-013-3376-9. Epub 2013 Nov 20.

PMID:
24254204
9.

Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.

Piardi T, Gheza F, Ellero B, Woehl-Jaegle ML, Ntourakis D, Cantu M, Marzano E, Audet M, Wolf P, Pessaux P.

Ann Surg Oncol. 2012 Jun;19(6):2020-6. doi: 10.1245/s10434-011-2170-9. Epub 2011 Dec 17.

PMID:
22179632
10.

Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.

Lee KK, Kim DG, Moon IS, Lee MD, Park JH.

J Surg Oncol. 2010 Jan 1;101(1):47-53. doi: 10.1002/jso.21415.

PMID:
19798686
11.

A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.

Banerjee S, Wang DS, Kim HJ, Sirlin CB, Chan MG, Korn RL, Rutman AM, Siripongsakun S, Lu D, Imanbayev G, Kuo MD.

Hepatology. 2015 Sep;62(3):792-800. doi: 10.1002/hep.27877. Epub 2015 Jul 1.

12.

Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.

Jiang L, Liao A, Wen T, Yan L, Li B, Yang J.

Transpl Int. 2014 Jun;27(6):562-9. doi: 10.1111/tri.12297. Epub 2014 Apr 2.

13.

Significance of incorporation of model for end-stage liver disease score with TNM staging in patients with hepatocellular carcinoma undergoing hepatic resection.

Ling CH, Chau GY, Hsia CY, King KL.

Hepatogastroenterology. 2013 Jul-Aug;60(125):1142-7. doi: 10.5754/hge11939.

PMID:
23803377
14.
15.

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.

Ruzzenente A, Capra F, Pachera S, Iacono C, Piccirillo G, Lunardi M, Pistoso S, Valdegamberi A, D'Onofrio M, Guglielmi A.

J Gastrointest Surg. 2009 Jul;13(7):1313-20. doi: 10.1007/s11605-009-0903-x. Epub 2009 May 6.

PMID:
19418103
16.

Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.

Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, Decaens T, Hurtova M, Memeo R, Mallat A, Duvoux C.

Ann Surg. 2009 Nov;250(5):738-46. doi: 10.1097/SLA.0b013e3181bd582b.

PMID:
19801927
17.

Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors.

Shindoh J, Andreou A, Aloia TA, Zimmitti G, Lauwers GY, Laurent A, Nagorney DM, Belghiti J, Cherqui D, Poon RT, Kokudo N, Vauthey JN.

Ann Surg Oncol. 2013 Apr;20(4):1223-9. doi: 10.1245/s10434-012-2739-y. Epub 2012 Nov 21.

18.

Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.

Zhao WC, Fan LF, Yang N, Zhang HB, Chen BD, Yang GS.

Eur J Surg Oncol. 2013 Aug;39(8):858-64. doi: 10.1016/j.ejso.2013.04.003. Epub 2013 May 11.

PMID:
23669199
19.

Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.

Kim JM, Kwon CH, Joh JW, Choi MS, Lee JH, Koh KC, Paik SW, Kim GS, Kim SJ, Lee SK, Yoo BC.

Transplant Proc. 2012 Mar;44(2):403-8. doi: 10.1016/j.transproceed.2012.01.067.

PMID:
22410028
20.

Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.

Lei Z, Li J, Wu D, Xia Y, Wang Q, Si A, Wang K, Wan X, Lau WY, Wu M, Shen F.

JAMA Surg. 2016 Apr;151(4):356-63. doi: 10.1001/jamasurg.2015.4257.

PMID:
26579636

Supplemental Content

Support Center